Valuation: Boston Scientific Corporation

Capitalization 111B 93.38B 85.17B 81.32B 151B 10,038B 157B 991B 393B 4,847B 416B 407B 16,942B P/E ratio 2025
49.1x
P/E ratio 2026 * 30.1x
Enterprise value 120B 101B 91.96B 87.79B 163B 10,837B 169B 1,070B 425B 5,234B 449B 440B 18,292B EV / Sales 2025
7.04x
EV / Sales 2026 * 5.23x
Free-Float
84.69%
Yield 2025 *
-
Yield 2026 * -
1 day+0.82%
1 week-2.02%
Current month-20.10%
1 month-20.28%
3 months-27.23%
6 months-28.25%
Current year-21.63%
1 week 72.69
Extreme 72.69
76.37
1 month 72.69
Extreme 72.69
94.75
Current year 72.69
Extreme 72.69
100.9
1 year 72.69
Extreme 72.69
109.5
3 years 45.92
Extreme 45.925
109.5
5 years 34.98
Extreme 34.98
109.5
10 years 16.62
Extreme 16.62
109.5
Manager TitleAgeSince
Chief Executive Officer 61 01/11/2011
Director of Finance/CFO 52 30/06/2025
Chief Operating Officer 58 01/05/2022
Director TitleAgeSince
Director/Board Member 61 01/04/2009
Chairman 61 03/05/2016
Director/Board Member 74 01/03/2014
Change 5d. change 1-year change 3-years change Capi.($)
+0.82%-2.02%-29.57%+58.06% 111B
-0.98%-7.00%-5.08%-11.66% 190B
+1.51%-0.47%-18.42%+101.52% 173B
-1.10%-1.86%+3.04%-17.04% 150B
+0.79%-1.74%-29.86%-20.76% 53.87B
-0.75%-3.61%-0.42%-0.94% 44.03B
+2.78%-7.02%+8.40%+18.06% 36.79B
+2.15%-0.38%-12.87%+10.65% 36.61B
+0.74%-2.91%-6.58%-17.79% 35.58B
-1.19%-1.96%-25.99%-42.05% 32.52B
Average +0.48%-2.49%-11.74%+7.80% 86.27B
Weighted average by Cap. +0.21%-2.46%-11.40%+19.79%

Financials

2025 2026 *
Net sales 20.07B 16.91B 15.43B 14.73B 27.34B 1,818B 28.4B 179B 71.23B 878B 75.28B 73.73B 3,068B 22.29B 18.78B 17.13B 16.36B 30.36B 2,019B 31.54B 199B 79.1B 975B 83.6B 81.88B 3,408B
Net income 3.01B 2.54B 2.31B 2.21B 4.1B 273B 4.26B 26.92B 10.69B 132B 11.29B 11.06B 460B 3.66B 3.09B 2.82B 2.69B 4.99B 332B 5.18B 32.75B 13B 160B 13.74B 13.46B 560B
Net Debt 8.83B 7.44B 6.79B 6.48B 12.02B 800B 12.49B 78.92B 31.33B 386B 33.11B 32.43B 1,350B 5.7B 4.8B 4.38B 4.18B 7.76B 516B 8.06B 50.93B 20.22B 249B 21.37B 20.93B 871B
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (64.2%): products used in cardiology surgeries (24.6% of net sales), peripheral surgeries (22.4%), cardiac rhythm management (21.2%), electrophysiology tests (17.7%) and other (14.1%); - endodontic surgery (29.2%): equipment used in endoscopy (55% of net sales), and urology (45%) ; - neuromodulation (6.6%). Net sales are distributed geographically as follows: the United States (61%), Europe/Middle East/Africa (19.3%), Asia/Pacific (16%) and other (3.7%).
Employees
53,000
Date Price Change Volume
13/02/26 74.73 $ +0.82% 13,452,417
12/02/26 74.12 $ +0.88% 16,871,948
11/02/26 73.47 $ -1.05% 20,102,918
10/02/26 74.25 $ +0.18% 21,080,942
09/02/26 74.12 $ -2.82% 21,133,732
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
74.73USD
Average target price
105.41USD
Spread / Average Target
+41.05%

Quarterly revenue - Rate of surprise